Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic

Keyphrases

• Alzheime's Disease 100%
• Alzheimer's Disease 100%
• Alzheimer's Disease Biomarkers 25%
• Amyloid Precursor Protein 25%
• Assay Development 25%
• Biomarker Development 25%
• Biomarker Discovery 25%
• Biomarker Identification 25%
• Biomarker Validation 25%
• Blood Biomarkers 100%
• Blood-based 25%
• Cardiovascular Disease 25%
• Cerebrospinal Fluid 25%
• Clinical Application 25%
• Clinical Diagnostics 25%
• Clinical Research 25%
• Clinical Treatment 25%
• Clinical Trials 25%
• Cognitive Deficits 25%
• Current Landscape 25%
• Development Pathways 25%
• Diagnostic Monitoring 25%
• Disease Mapping 100%
• Disease Pathophysiology 25%
• Disease-associated 25%
• Early Detection 25%
• High Cost 25%
• Highly Accurate 25%
• International Working Groups 25%
• Invasiveness 25%
• Neuropathological Changes 25%
• Oncological Diseases 25%
• Pathophysiological Changes 25%
• Precision Medicine 25%
• Research Monitoring 25%
• Targeted Therapy 25%
• Tau Protein 25%
• Therapy Monitoring 25%
• Tiered Approach 25%

Medicine and Dentistry

• Alzheimer's Disease 100%
• Alzheimer's Disease Biomarkers 25%
• Amyloid Protein 25%
• Biological Marker 100%
• Cardiovascular Disease 25%
• Cerebrospinal Fluid 25%
• Clinical Research 25%
• Clinical Trial 25%
• Cognitive Defect 25%
• Disease Mapping 100%
• Health Care Cost 25%
• Oncology 25%
• Pathophysiology 50%
• Personalized Medicine 25%
• Polyethylene Terephthalate 25%
• Targeted Therapy 25%
• Tau Protein 25%

Immunology and Microbiology

• Alzheimer's Disease 100%
• Cardiovascular System 20%
• Cerebrospinal Fluid 20%